< Zurück zu den aktuellen Neuigkeiten & Events

UPC

Unitary Patent Renewal Fees – proposed figures revealed

März 2015

Ever since the prospect of a Unitary Patent for Europe became a reality, the subject of cost has been hotly debated. Will a Unitary Patent save me money? But with so many unknowns, the question has been like a puzzle.

According to various sources, we could have the first piece in the puzzle, with the EPO having made a proposal on the level of renewal fees. In a document „Proposals for the level of renewal fees for European patents with unitary effect“, (which we’ve yet to see a copy of) submitted by the President of the EPO to the Select Committee of the Administrative Council for their opinion, the EPO has come up with the following proposal:

To meet the requirements set out in Article 12 of the Regulation on the Unitary Patent, the EPO has allegedly proposed the following structure for setting unitary patent renewal fees:

  • years 3 to 5: the level of the EPO’s internal renewal fees (IRF) [these are the fees payable to the EPO for pending patent applications currently]
  • years 6 to 9: a transitional level between the IRF level and the year 10 level
  • from year 10, a level equivalent to the total sum of the national renewal fees payable in the states in
    which European patents are most frequently validated (TOP level)

Furthermore, based on this, two specific proposals are made – one where the Year 10 onwards level is based on current renewal fee levels for FOUR European countries (TOP 4 level) and one where the Year 10 onwards level is based on current renewal fee levels for FIVE European countries (TOP 5 level) but with a reduction for certain categories of patentees, namely SMEs, natural persons, non-profit organisations, universities and public research
organisations.

Based on these proposals, the cost of obtaining a UP would be more expensive than current filing strategies, if for example patentees usually validate in 3 or less states. And of course, given that it will not be possible to be selective as to EP countries which are maintained throughout the life of the patent, there is no option to scale down costs towards the end of the patent term.

We still need more pieces in the puzzle to get the full picture on whether a UP will save money in the long run.

Aktuelle Neuigkeiten

IAM-Patent 1000 2023

Die IAM Patent 1000 2023-Rangliste ist jetzt verfügbar, und wir freuen uns, dass 31 Anwältinnen und Anwälte als Weltklasse-Einzelpersonen in dem Leitfaden anerkannt sind. Die Kanzlei ist auch stolz darauf, …

Weiterlesen
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Veranstaltungsdetails
Event - 28th-30th November 2023

IPBC Asia event

The IPBC Asia event is due to go ahead on 28th-30th November, at The Palace Hotel in Tokyo. This event will have experts from the IP market attending and sharing …

Veranstaltungsdetails

KI-gestützte personalisierte Medizin

Die Integration von künstlicher Intelligenz (KI) in das Gesundheitswesen hat eine neue Ära der personalisierten Medizin eingeläutet, die wirksamere und maßgeschneiderte Behandlungen für Patienten verspricht. Traditionelle medizinische Ansätze gehen oft …

Weiterlesen